• Blog
  • Veterinary Vaccines Market Report

    Veterinary Vaccines Market Report

    Veterinary Vaccines Market Report
    Report code - SRHL287 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Veterinary Vaccines Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on Veterinary Vaccines Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Veterinary Vaccines Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Veterinary Vaccines Market is projected to grow from USD 8.24 billion in 2020 to USD 12.81 billion by 2026 at a CAGR of over 7.6% during the forecast period.

    Figure: Global Veterinary Vaccines Market Size, 2020-2026 (USD Billion)

    Veterinary-Vaccines-Market-Forecast

    Wish to get a free sample report? Click here.

    What are Veterinary vaccines?

    Veterinary vaccines consist of vaccines that are used for the treatment and prevention of life-threatening diseases in animals. These veterinary vaccines help to reduce animal suffering and transmission of disease-causing microorganisms in the animal population. These vaccines are primarily used to improve the immunity power of animals by improving the health conditions of both companion and non-companion animals, which further prevents the transmission of diseases from animals to humans.

    Key Players

    Key players operating in the global veterinary vaccines market are-

    • Merck & Co., Inc. (The U.S),
    • Zoetis (The U.S),
    • Boehringer Ingelheim International GmbH (Germany),
    • Virbac, Inc. (The U.S),
    • Biogénesis Bagó S.A. (Argentina),
    • Indian Immunologicals Limited (India),
    • Elanco (The U.S),
    • Ceva (France),
    • Phibro Animal Health Corporation (The U.S), and
    • Neogen Corporation (The U.S).

    Market Dynamics

    Growing livestock population and increasing animal husbandry along with the commercialization of animal products are the prime factors augmenting the market growth.

    • Also, the perpetual introduction of technologically advanced veterinary vaccines, as well as the outbreak of livestock and zoonotic diseases, further boost the product demand.
    • In addition, the market has witnessed a radical shift from live attenuated vaccines to DNA vaccines and is rapidly implementing recombinant vaccine solutions, which provide immense opportunities to the industry players.
    • However, the high cost of vaccines can impede market expansion.

    Segment Analysis

    Technology Trends

    By technology, the veterinary vaccines market has been segmented into attenuated live vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others.

    • Under these, the attenuated live vaccines segment held the highest market share in 2020 and is likely to register a substantial CAGR during the review period.
    • Live attenuation is the oldest vaccination method that is used in the veterinary field.
    • This method is also under trial for the development of additional applications.

    Regional Trends

    By region, North America accounted for the highest market share in 2020 and is projected to grow at a steady CAGR during the assessment period.

    • This is mainly ascribed to the increasing incidence of canine disorders, which, in turn, adoption of vaccination for the same coupled with the rising pet population in the U.S. is one of the key factors contributing to the expansion of the market share of the region.

    COVID-19 Impact on Global Veterinary Vaccines Market

    The outbreak of the COVID-19 virus has considerably affected the veterinary vaccines industry owing to stringent lockdown measures and the restricted movement of people. The unprecedented outbreak of coronavirus (SARS?CoV?2) has overshadowed the negatively affected veterinary vaccines industry. The veterinary appointments were cancelled or postponed, thus affecting the veterinary vaccines market.

    Critical Questions Answered in the Report

    • What are the key trends in the global veterinary vaccines market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global veterinary vaccines market?
    • What are the key strategies adopted by the major vendors to lead in the global veterinary vaccines market?
    • What is the market share of the top vendors?

    Wish to know more about the study? Click here.

    Target Audience

    • Veterinary vaccines companies
    • Veterinary clinics
    • R&D companies
    • Hospitals
    • Drug manufacturing companies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The veterinary vaccines market is expected to witness an impressive growth of 7.6% CAGR in the foreseeable future.

    Merck & Co., Inc. (The U.S), Zoetis (The U.S), Boehringer Ingelheim International GmbH (Germany), Virbac, Inc. (The U.S), Biognesis Bag S.A. (Argentina), Indian Immunologicals Limited (India), Elanco (The U.S), Ceva (France), Phibro Animal Health Corporation (The U.S) and Neogen Corporation (The U.S) are among the key players in the veterinary vaccines market.

    The veterinary vaccines market size is expected to reach USD 12.81 billion in the coming years.

    North America accounted for the largest share in the veterinary vaccines market in 2020.

    The attenuated live vaccines segment held the highest share in the veterinary vaccines market in 2020.

    Growing livestock population and increasing animal husbandry along with the commercialization of animal products are the prime factors driving the growth of veterinary vaccines market.

    Veterinary vaccines companies, Veterinary clinics, R&D companies, Hospitals, Drug manufacturing companies are the target audience in the veterinary vaccines market.

    •